Deconstructing glioblastoma complexity reveals its pattern of development

Study identifies rapidly dividing cancer stem cells that can respond to new therapies

Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.

Brain tumour awareness week

Providing excellent care and the latest research to help patients

The Brain Tumour Foundation of Canada estimates that 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. This Brain Tumour Awareness Week we recognize the toll this disease takes on patients and the work being done to improve their quality of life.

Brain cancer fundraiser leads to important discovery

Brain cancer begins in stem cells, targeting them may prevent tumour growth

Researchers at the Montreal Neurological Institute and Hospital (The Neuro) have found an exciting new way of treating brain cancer.

Late stage brain cancer cells are heterogeneous — they differ down to the molecular level. This makes developing treatments at this stage difficult, because a drug that may be effective against one cell may not be effective against another.

Cancer probe chosen for top science discovery

Québec Science magazine’s 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner.

The Neuro’s top brain cancer fundraiser returns

A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.

An infallible hand-held probe to aid cancer surgery

Patients with common widespread forms of cancer will enjoy longer life expectancy and reduced risk of recurrence thanks to a multimodal optical spectroscopy probe developed by Canadian researchers. 

A Brilliant Success

A Brilliant Night raises $1 million for brain cancer research

A Brilliant Night raised an astounding $1 million for brain cancer research at its gala event on Oct. 19.

A Brilliant Night 2016

Inspiring event to raise money for brain cancer research

An evening filled with personal stories from those whose lives have been affected by brain cancer will once again contribute to the fight against the disease.

Continuing the fight against brain cancer

Fundraiser to support research to help defeat cancer suffered by Tragically Hip frontman

With the farewell concert of legendary Canadian band The Tragically Hip now past, The Neuro is asking the public to not forget the toll brain cancers take on Canadians, and the need to find new therapies.

The Neuro enrolls Canada’s first patient in a new clinical trial for the treatment of brain tumours

Dr.

More than $604,000 Raised for the Fight Against Brain Tumours

Montreal, Quebec (October 22, 2015) – Last night the inaugural A Brilliant Night - a gala fundraiser to benefit The Montreal Neurological Institute and Hospital -The Neuro- at McGill University and the MUHC, raised more than $604,000 for brain tumour research.

A Brillant Night - Raising awareness and funds for brain tumor research

Join us for the first edition of A Brilliant Night at the spectacular new Rio Tinto Alcan Planetarium in Montreal for a unique event on October 21st to support the latest in brain tumor research at the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the McGill University Health Centre.

A BRILLIANT CAUSE

Revolutionary new probe zooms in on cancer cells

Improves tumour surgeries and extends survival times for brain cancer patients

VIDEO: http://bit.ly/1EYjsTV